Unlock instant, AI-driven research and patent intelligence for your innovation.

An animal model for studying atherosclerotic lesions

A technique of atherosclerosis, animal model, applied in aspects, a specific aspect, mice, research of animal models of atherosclerosis, drug, prevention and/or treatment of atherosclerosis, screening for treatment of atherosclerosis Like sclerosing drugs, rodents, / pathological differences in the field, able to address issues such as animal models that do not preserve SPT function

Inactive Publication Date: 2009-08-26
THE RES FOUND OF STATE UNIV OF NEW YORK
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, despite all studies on SPT to date, no direct in vivo evidence of SPT function or animal models used to study such function has been preserved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An animal model for studying atherosclerotic lesions
  • An animal model for studying atherosclerotic lesions
  • An animal model for studying atherosclerotic lesions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 3

[0094] In yet another embodiment, the present invention provides an animal model for studying metabolic syndrome or insulin resistance, obesity, and diabetes, wherein the genome of the model animal contains a subunit encoding serine palmitoyl-CoA transferase (SPT) Heterozygous division of at least one endogenous gene.

[0095]The invention is further illustrated by the following non-limiting examples.

Embodiment 1

[0097] Preparation of animal models for studying atherosclerosis

[0098] Construction of Sptlc1 Gene Replacement Vector

[0099] The 12kb mouse genome DNA fragment containing Sptlcl exons 7-10 from the mouse 129λ genome library was used for the construction of the targeting vector (Figure 1). PacI-linearized targeting vector was used for electroporation, and G418 was used to selectively select embryonic stem cells (ES). Southern blot analysis and PCR were used to screen targeted ES cells. Genomic DNA was digested with ECoRV, and a 350-bp DNA fragment only 3'to the targeting vector (Figure 2) was used as a probe for Southern blotting.

[0100] The wild type (WT) contains a 7.2 kb fragment, while the recombinant contains a 5.5 kb fragment without exons 7 or 8 ( Figure 1B ). Use primer pair SrSA5 and Neo2 to do PCR. The primer SrSA5 is located outside the short arm and has the sequence 5'-TCAGAGATTCTCCATTGCCACTG-3' (SEQ ID NO: 1). The primer Neo2 is located in the 5'-promoter reg...

Embodiment 2

[0128] Sptlc1 and Sptlc2 lack reduced liver Sptlc1 and Sptlc2 mRNA, quality and activity levels

[0129] Replace exons 7 and 8 with neo gene ( Figure 1A ), using forward selection to target the mouse Sptlcl gene. To screen for homologous elements, the genomic DNA of ES cells was digested with EcoRV. Use the 350bp fragment within intron 6 and outside the target sequence to analyze the Southern blot ( Figure 1B ), 5 out of 150 ES cell clones showed homologous binding. Adding the 5.5-kb signal to the endogenous 7.2-kb signal showed specific binding at the Sptlc1 gene locus ( Figure 1B ). The correctly targeted cells are injected into the C57BL / 6J host blastocyst. Six chimeras (3 males, 3 females) were produced, all of these male chimeras spread the split Sptlcl alleles through the germline. Heterozygous mice obtained by crossing. After screening 300 offspring, no homozygous animals were found. The embryos from 15 to 20 days were screened, and no homozygous mice were found. As expe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an animal model for atherosclerosis and a transgenic knockout animal. Methods for preventing and / or treating atherosclerosis are also provided. More specifically, the present invention provides methods of preventing and / or treating atherosclerosis by administering to a subject in need thereof an inhibitor of Serine palmitoyl-CoA transferase (SPT) or its subunit.

Description

[0001] The present invention relates to animal models, genes and biochemical / biomedical technologies, especially animal models for studying atherosclerosis. The present invention also relates to methods for screening drugs for treating atherosclerosis and methods for preventing and / or treating atherosclerosis. More specifically, the present invention relates to a method for preventing and / or treating atherosclerosis by administering an inhibitor of serine palmitoyl-CoA transferase (SPT) or its subunits to a subject in need. Background of the invention [0002] Serine palmitoyl-CoA transferase (SPT) is the rate-limiting enzyme in sphingolipid biosynthesis (1). It has long been known that SPT plays an important role in the metabolism of sphingolipids. In addition, SPT activity in rat liver (2) and lung (3) is positively correlated with sphingolipid formation in those tissues. Feeding high cholesterol feed improves SPT activity in rabbit aorta (4). It has also been found that the decr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/00A01K67/027A61K38/00
CPCA01K2217/075A01K2267/0375G01N33/5088A01K2227/105C12N9/1029A01K67/0276C12N15/8509A61P9/10
Inventor X·江M·R·霍亚蒂
Owner THE RES FOUND OF STATE UNIV OF NEW YORK